Research Grid (R.grid) are experts in AI-powered clinical trials. We have developed two industry-leading products, Inclusive and TrialEngine, which form the only end-to-end solution to automate the back-office of clinical trials, from pre-trial to trial close.
By leveraging our AI-powered automation engine, Research Grid provides industry-leading solutions designed to tackle trial management bottlenecks and automate manual processes, supporting our mission of making clinical trials faster and more successful. Together, they form the only end-to-end platform to automate the back office of clinical trials, from pre-trial to trial close.
Inclusive is a smart patient, community engagement sourcing and management platform for use in the early trial preparation phase. It has created the largest patient network in the world, providing access to more than 440 million patients across more than 96,000 communities.
TrialEngine is a smart clinical trial automation system (CTAS) that handles the administration, data, and reporting workflows during the trial and post-trial. It leverages custom AI algorithms and process automation to complete tasks such as protocol development, study documents and data extraction in a matter of minutes.
Inclusive is a smart patient, community engagement sourcing and management platform for use in the early trial preparation phase. It has created the largest patient network in the world, providing access to more than 440 million patients across more than 96,000 communities.
TrialEngine is a smart clinical trial automation system (CTAS) that handles the administration, data, and reporting workflows during the trial and post-trial. It leverages custom AI algorithms and process automation to complete tasks such as protocol development, study documents and data extraction in a matter of minutes.
We make patient recruitment and engagement easy while drastically reducing administrative errors to give every trial the best chance of success.
98.5% enrolment rate
across all trials
73% of enrolled patients
belong to ethnic minorities
99.25% patient retention
through automation and engagement
98.5% enrolment rate across all trials
73% of enrolled patients belong to ethnic minorities
99.25% patient retention through automation and engagement
98.5% enrolment rate across all trials
73% of enrolled patients belong to ethnic minorities
99.25% patient retention through automation and engagement
I’m loving all of the community networks that Inclusive has to offer in the database! The ease of sending mass emails is a huge plus!
A.F
Community Engagement Manager
We have found a partner in Research Grid’s Inclusive platform that simply understands us. There is an intimate level of knowledge that can only be derived from experience.
N.B
Director Global Patient Engagement
TrialEngine’s document automation is truly a game changer and significantly increases our agility.
Dr N.S.
CEO at industry player for commercial CRF
Working with the Inclusive team was fun, efficient and effective. They are doing everything in a short time and making it simple. Inclusive itself is an interesting platform that allows us in Indonesia to connect with other communities and researchers in the world who share the same focus.
S.S.
Indonesian SMA Community-Komunitas Spinal Muscular Atrophy
I love the platform. It actually has the potential to solve real problems in clinical trial operations and patient engagement and retention.
D.W
Vice President, Law Data Enablement Johnson & Johnson Medtech
Inclusive plays a noticeable role in today`s world of globalization. Different community and research groups from all around the world are being brought together on one platform, allowing easier connection and communication.
M.H.
Friedreich Ataxia Lebanese Association (FALA)